SANUWAVE Health, Inc. (NASDAQ:SNWV) COO Peter Stegagno Sells 1,862 Shares

SANUWAVE Health, Inc. (NASDAQ:SNWV - Get Free Report) COO Peter Stegagno sold 1,862 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $27.71, for a total value of $51,596.02. Following the completion of the sale, the chief operating officer now owns 2,032 shares of the company's stock, valued at $56,306.72. The trade was a 47.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

SANUWAVE Health Trading Down 1.2%

SANUWAVE Health stock traded down $0.38 during trading hours on Thursday, reaching $30.99. The stock had a trading volume of 56,451 shares, compared to its average volume of 34,774. SANUWAVE Health, Inc. has a 52 week low of $5.17 and a 52 week high of $39.50. The company has a market capitalization of $265.15 million, a P/E ratio of -6.80 and a beta of 1.19. The stock has a 50 day moving average of $29.59.

SANUWAVE Health (NASDAQ:SNWV - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported ($0.66) earnings per share (EPS) for the quarter. The company had revenue of $9.34 million during the quarter.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Strategic Investment Solutions Inc. IL purchased a new stake in SANUWAVE Health in the first quarter valued at approximately $47,000. Goldman Sachs Group Inc. purchased a new stake in shares of SANUWAVE Health during the first quarter worth about $337,000. AWM Investment Company Inc. purchased a new position in shares of SANUWAVE Health in the first quarter valued at approximately $18,153,000. Finally, Solas Capital Management LLC purchased a new position in SANUWAVE Health in the 1st quarter valued at $20,658,000. Hedge funds and other institutional investors own 42.53% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded SANUWAVE Health from a "buy" rating to a "hold" rating in a report on Saturday, May 24th.

About SANUWAVE Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.